This holiday season please consider giving the gift of hope by making a donation to Jett Foundation's annual appeal. Your contributions allow us to make a direct impact on the daily lives of patients and families affected by Duchenne.   
       
  • Camp Promise, a week filled with uncontrollable laughter, transformative adaptive activities and unforgettable experiences. 
  • Educational and Advocacy Programs, provide resources and knowledge to our community and educate on policies that improve the overall landscape of Duchenne. 
  • Matching Gift Program, alleviates the financial hardship of expensive adaptive medical equipment that many families struggle with. 
  • JettRide, spreads awareness for Duchenne and provides a healthy outlet to raise awareness and funds for families affected by Duchenne.

 
Other ways to give:
  • Does your company has a matching gift program? Don't forget to sign up and double your gift to Jett Foundation. 
  • Did you know your Amazon purchases can help end Duchenne? Sign up for Amazon Smile, select Jett Foundation as your charity, and a percentage of all your purchases will be donated to help end Duchenne.  
THANK YOU for supporting our mission !
Best wishes for a healthy and happy holiday season.
~Christine McSherry and Jett Foundation Team 
 
 
Jett Foundation's Shine a Light on Duchenne  Gala!

Join Us...  
Thursday, January 26, 2017
The Museum of Science 
7PM - 11PM
 
 
For more information and 
sponsorship opportunities 
please  email: 

We will be honoring special guests:
Bill Brett, Boston's Photographer,  The Spotlight Award
Cindy Quitzau, Founder, Gals for Cal,  The Lantern Award
The Flatley FoundationThe Beacon Award

You don't want to miss out on this wonderful night! 
Jett Foundation Eduational Roundtable's

Please click here for additional information and for 2017 dates and locations.
The Latest Industry Partner News
 
Jett Foundation collaborates with many industry partners who are working towards potential treatments for Duchenne.  Read more about their recent updates below.  For additional information on Duchenne clinical trials go to  Clinicaltrials.gov
 
PTC Therapeutics CHMP recommends renewal of Translarn's marketing authorization for nonsense mutation Duchenne muscular dystrophy based on continued positive benefit-risk assessment. 
 
Capricor Therapeutics to expand clinical development program in Duchenne muscular dystrophy. 
 
NS Pharma announces fast track designation to NS-065/NCNP-01 for the treatment of Duchenne.
 
Pfizer's Duchenne program update 

WEBSITE  |   ABOUT  |   NEWS  |  EVENTS |  PROGRAMS | CONTACT
Like us on Facebook     Follow us on Twitter    
Copyright © 2015. All Rights Reserved.